Merck & Co (MRK)
$83.02
0.51 (0.62%)
MRK Stock Quote Delayed 15 Minutes
Previous Close
$83.02
Market Cap
223.35B
PE Ratio
143.14
EPS
0.58
Volume (Avg. Vol.)
6.66M
Day's Range
82.38 - 83.28
52-Week Range
66.10 - 87.35
Dividend & Yield
1.92 (2.31%)
MRK Stock Predictions, Articles, and Merck & Co News
Dow Jones Today: Fed Obliges, Stocks Don’t
A divided Federal Reserve is a new issue for investors to consider. Read more about what happened in the Dow Jones today.
3 Big Stock Charts for Monday: Merck, Facebook and Microsoft
The stock charts of MSFT, FB and MRK have earned a closer technical look as the new trading week kicks off.
Bristol-Myers Squibb Stock Has Upside — But Mind the Risks
Bristol-Myers Squibb stock touched a multi-year low last month. But the BMY stock price is cheap enough now to take on real risks.
Why Bristol-Myers Squibb Stock Is Stumbling Ahead of Earnings
Investors turned sour on BMY stock after the Celgene buyout. Will a solid Q2 earnings report change the sentiment for the better?
A Pairs Prescription for CVS Stock and Merck
Longstanding cycles in CVS Health and Merck are at risk of changing and offering profits to spread traders buying CVS stock and shorting MRK.
Friday’s Vital Data: Bed Bath & Beyond, CVS and Merck
Options trading was buzzing in Bed Bath & Beyond, CVS, and Merck on Thursday. Here are the metrics that matter moving forward.
3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
4 Drug Stocks Getting Smashed
Drug stocks are falling on fears of President Trump's next move on drug prices. Here's a look at the charts.
Dow Jones Today: Averting Catastrophe, but Nothing to Brag About
As has been noted in this space, market participants are pricing in the following Fed facts: no interest rate cut this month and no cuts totaling 50 basis points this year. Hope burns eternal for a rate reduction of 25 basis points, but Powell's two-day testimony and the June meeting minutes could indicate otherwise.
Two Healthcare Stocks in the XLV Fund Stand Out
MRK stock and ABBV stock are promising healthcare stocks to invest in from the XLV fund. MRK is 6% of holdings and AbbVie makes up 3.5%.
Profit from Earnings Volatility With This Biotech Stocks Pairs Trade
Play a friendly and widening price spread in biotech stocks with a well-place purchase in Merck and an equally smart short in AbbVie.
Why Investors Should Buy the Dip in MRK Stock
The fall in MRK, and other drug stocks, was based on fear of a drug price backlash that has not yet materialized.
Why Is Bristol-Myers Near 52-Week Lows?
Investors are punishing Bristol-Myers on the markets more than they should. BMY stock's acquisition of Celgene isn't the only reason.
Risk-Tolerant Investors, Turn Your Eyes to Exelixis Stock
Smaller-capitalization biotechs can be riskier investments, but EXEL stock has more than just promise off and on the price chart and is readying to be purchased.
10 Dow Jones Stocks Holding the Blue Chip Index Back
Pfizer, Walgreens and Merck are just three of the Dow Jones stocks that have kept the index from doing as well as other market indices have this year.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
